Thrombus formation can have morbid consequences when ADAMTS13 activity is inhibited by the presence of autoantibodies, as in TTP, or when ADAMTS13 is absent, as in congenital TTP (4). This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.